Business Wire

TRAXENS

11.6.2019 09:02:08 CEST | Business Wire | Press release

Share
Traxens Equips Reefer Containers with State-of-the-Art Tracking Telematics Technology for Indonesian Shipping Partner PT Trans Kontainer Solusindo (TKS)

Traxens, a company providing high-value data and services for the supply chain industry, today announces it has equipped the smart reefer containers of a leading Indoniesian NVOCC company, PT TKSolusindo, with its patented Traxens solution.

PT TKSolusindo is a major Non-Vessel Operating Common Carrier (NVOCC) in Indonesia, a country made up of 17,000 islands, where domestic container trades are essential in the daily life of inhabitants. The containers, delivered from the Taicang and Qingdao factories of China International Marine Containers (CIMC), were equipped with Traxens’ smart solutions in only a few days. These now bring PT TKSolusindo, and its clients, full visibility of shipped cargo in the controlled-atmosphere containers throughout all logistical legs of the journey.

Traxens’ solution addresses key challenges in the shipping industry faced by both asset owners and cargo owners. With the support of telematics, asset owners can control costs and develop more agile business problem solving, while cargo owners can easily keep track of their containers, bringing improved business processes and decision making capabilities. Reduced operational costs, improved supply chain efficiency, enhanced security and the opportunity to extend offerings to customers are amongst the key benefits gained through Traxens’ smart solutions. The whole shipping ecosystem, including ports, freight forwarders, insurance and financial institutions, can also benefit from the value-added data gathered by Traxens’ cutting-edge technology.

Traxens offers a comprehensive solution for the reefer industry, which comprises the company’s Reefer Fleet Management and Reefer Door-to-door Monitoring cloud-based applications via the Traxens-Hub, which collects data from Traxens-Box devices installed on containers.

“Traxens’s novel technology is a great addition to the services we provide to our customers, who are keen on staying informed about their cargo’s whereabouts and conditions at all times,” said Glenn Manoppo from PT TKSolusindo. “The reasonable and competitive pricing offered by Traxens were important in our decision when selecting the right partner for the digital transformation of our operations.”

“We are delighted that our reefer tracking technology was chosen by PT. TKSolusindo and we believe that our solution will support the company with the digital transformation of its shipping business,” said Jacques Delort, managing director of Traxens. “We look forward to further co-operations in Asia, a region where domestic and international shipping is crucial for economic success.”

Traxens counts major BCOs among its customers; it also partners with major shipping lines in providing bespoke tracking data for containers.

About PT Trans Kontainer Solusindo (TKSolusindo)

PT TKSolusindo is a subsidiary of an Integrated Cold Chain Solution Company of PT. Kiat Ananda Group, who became the first integrated services provider for refrigerated goods in Indonesia.

PT TKSolusindo specializes in domestic inter-island transport using reefer containers to reach other areas in Indonesia to distribute customers’s goods. The company was set up in 2014, and is now the largest NVOCC in Indonesia with major customers, including international brands such as Unilever, Pizza Hut, Starbucks, Yakult Probiotic, Kentucky Fried Chicken, Greenfield Diary, etc. and local brands such as Hypermart Retail, Hero Retail, Transmart Retail, Charoen Pokphand Indonesia etc. PT TKSolusindo manages more than 500 fleets, generators and trucking.

PT TKSolusindo will develop its international forwarding to support the group trading business in the future.

ABOUT TRAXENS

Traxens generates, collects, consolidates, enriches and transforms logistics asset data into actionable insight for its clients in the maritime, rail and supply chain industries.

The company’s breakthrough Internet-of-Big-Things technology provides comprehensive, real-time information for managing logistics assets anywhere in the world. Traxens’ solutions digitally transform multi-modal supply chains, enabling customers to reduce costs, optimize investments, comply with environmental regulations and deliver premium services to their customers. Traxens’ IoT solution received the Frost & Sullivan’s Technology Leadership Award in 2019.

www.traxens.com

Contact:

PRESS CONTACT : Géraldine Saunière DIRECTOR OF COMMUNICATIONS Mail: g.sauniere@traxens.com Tel: +33 695 915 899

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye